These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 28795299)

  • 1. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study).
    Fu M; Ahrenmark U; Berglund S; Lindholm CJ; Lehto A; Broberg AM; Tasevska-Dinevska G; Wikstrom G; Ågard A; Andersson B;
    Clin Res Cardiol; 2017 Dec; 106(12):960-973. PubMed ID: 28795299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving Guideline-Directed Heart Rate ControlEarly Posthospitalization.
    Jungbauer CG; Maier LS; Emoto K; Zirille FM; Mirro MJ
    Am J Cardiol; 2019 Apr; 123(7):1096-1100. PubMed ID: 30683422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection Fraction.
    Ibrahim NE; Januzzi JL; Rabideau DJ; Gandhi PU; Gaggin HK
    Am J Cardiol; 2017 Sep; 120(5):803-808. PubMed ID: 28728744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
    Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
    JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.
    O'Neal WT; Sandesara PB; Samman-Tahhan A; Kelli HM; Hammadah M; Soliman EZ
    Eur J Prev Cardiol; 2017 Jul; 24(11):1212-1219. PubMed ID: 28482692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction.
    Lan WR; Lin SI; Liao FC; Chang HY; Tsai CT; Wu YJ; Liu PY; Chen CH; Lee YH
    Am J Cardiol; 2021 Jul; 150():77-81. PubMed ID: 34006371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of resting heart rate in atrial fibrillation patients with heart failure with reduced ejection fraction.
    Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K
    Heart Vessels; 2020 Aug; 35(8):1109-1115. PubMed ID: 32144498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate reduction and exercise performance in recent onset heart failure with reduced ejection fraction: arguments for beta-blocker hypo-response.
    Verbrugge FH; Vrijsen J; Vercammen J; Grieten L; Dupont M; Mullens W
    Acta Cardiol; 2015 Oct; 70(5):565-72. PubMed ID: 26567816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
    Böhm M; Abdin A; Slawik J; Mahfoud F; Borer J; Ford I; Swedberg K; Tavazzi L; Batailler C; Komajda M
    Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation.
    Mordi IR; Santema BT; Kloosterman M; Choy AM; Rienstra M; van Gelder I; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Metra M; Ng LL; Ouwerkerk W; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Voors AA; Lang CC
    Clin Res Cardiol; 2019 Jul; 108(7):797-805. PubMed ID: 30610382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
    Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
    JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.